Neuromodulation Devices Market: How Neuromodulation Is Expanding Into Urology and New Indications
The global neuromodulation devices market was valued at USD 6.4 billion in 2025 and is projected to grow from USD 7.0 billion in 2026 to USD 13.9 billion by 2033, expanding at a CAGR of 10.4%. North America leads with a 43.4% revenue share, spinal cord stimulators are the top-selling product, and Parkinson's disease is the largest application segment. Neuromodulation — the use...
0 Comments 0 Shares 5 Views 0 Reviews
AC Mingle https://acmingle.com